These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


437 related items for PubMed ID: 19589444

  • 1. Dual renin-angiotensin system blockade in heart failure.
    McMurray JJ, Granger CB, Ostergren J, Yusuf S, Pfeffer MA, Swedberg K.
    J Am Coll Cardiol; 2009 Jul 14; 54(3):278; author reply 279-80. PubMed ID: 19589444
    [No Abstract] [Full Text] [Related]

  • 2. Dual renin-angiotensin system blockade: on the target.
    Robles NR.
    Int J Clin Pract; 2008 Aug 14; 62(8):1134-6. PubMed ID: 18705817
    [No Abstract] [Full Text] [Related]

  • 3. ACEI and ARB may also benefit CHF through immune system modulation (down-regulation of immune system).
    Fett JD.
    Int J Cardiol; 2005 Aug 03; 103(1):107. PubMed ID: 16061132
    [No Abstract] [Full Text] [Related]

  • 4. Combined blockade of the renin-angiotensin system with angiotensin-converting enzyme inhibitors and angiotensin II type 1 receptor antagonists.
    Azizi M, Ménard J.
    Circulation; 2004 Jun 01; 109(21):2492-9. PubMed ID: 15173039
    [No Abstract] [Full Text] [Related]

  • 5. [The important role of angiotensin receptor blocker on treatment of chronic heart failure].
    Huang J.
    Zhonghua Xin Xue Guan Bing Za Zhi; 2006 Sep 01; 34(9):773-4. PubMed ID: 17217679
    [No Abstract] [Full Text] [Related]

  • 6. Dual blockade of renin-angiotensin system in primary focal segmental glomerulosclerosis.
    Singh A.
    Nephrol Dial Transplant; 2006 Mar 01; 21(3):830-1. PubMed ID: 16278255
    [No Abstract] [Full Text] [Related]

  • 7. Medical agents acting on the renin-angiotensin-aldosterone axis for the treatment of heart failure.
    Kawano H, Node K.
    Hypertens Res; 2010 Mar 01; 33(3):192-3. PubMed ID: 20203682
    [No Abstract] [Full Text] [Related]

  • 8. Renin-angiotensin gene polymorphisms and neurohormonal inhibition.
    Pauly DF.
    Heart Fail Clin; 2010 Jan 01; 6(1):25-6. PubMed ID: 19945057
    [Abstract] [Full Text] [Related]

  • 9. Dual renin-angiotensin system blockade and kidney disease.
    Parving HH, Brenner BM, McMurray JJ, de Zeeuw D, Haffner SM, Solomon SD, Chaturvedi N, Pfeffer MA.
    J Am Coll Cardiol; 2009 Jul 14; 54(3):278-9; author reply 279-80. PubMed ID: 19589445
    [No Abstract] [Full Text] [Related]

  • 10. RAS blockers: Does sex matter? Re: Sex differences in the effectiveness of ARB and ACEI in patients with congestive heart failure - A population study: Marie Hudson et al. European Journal of Heart Failure 9 (2007) 602-609.
    Strauss MH, Hall A.
    Eur J Heart Fail; 2007 Sep 14; 9(9):963-4; author reply 964. PubMed ID: 17669685
    [No Abstract] [Full Text] [Related]

  • 11. [Dual blockade of the renin-angiotensin system--is it of clinical significance?].
    Pedersen OL.
    Ugeskr Laeger; 2004 Oct 18; 166(43):3797. PubMed ID: 15544107
    [No Abstract] [Full Text] [Related]

  • 12. Blockade of renin-angiotensin-aldosterone system in kidney and heart disease: how much do we need?
    Lim S.
    Acta Med Indones; 2008 Jan 18; 40(1):34-7. PubMed ID: 19054878
    [Abstract] [Full Text] [Related]

  • 13. Combination renin-angiotensin system blockade in hypertension.
    Doulton TW, Macgregor GA.
    Kidney Int; 2005 Oct 18; 68(4):1898. PubMed ID: 16164672
    [No Abstract] [Full Text] [Related]

  • 14. [Dual blockade of the renin-angiotensin system].
    Andersen NH, Mogensen CE.
    Ugeskr Laeger; 2004 Oct 18; 166(43):3799-803. PubMed ID: 15544108
    [No Abstract] [Full Text] [Related]

  • 15. Hyperkalemia risk and treatment of heart failure.
    Segura J, Ruilope LM.
    Heart Fail Clin; 2008 Oct 18; 4(4):455-64. PubMed ID: 18760757
    [Abstract] [Full Text] [Related]

  • 16. Progression of renal disease--can we forget about inhibition of the renin-angiotensin system?
    Mann JF, McClellan WM, Kunz R, Ritz E.
    Nephrol Dial Transplant; 2006 Sep 18; 21(9):2348-51; discussion 2352-3. PubMed ID: 16822789
    [No Abstract] [Full Text] [Related]

  • 17. Changes in kidney function following heart failure treatment: focus on renin-angiotensin system blockade.
    Blankstein R, Bakris GL.
    Heart Fail Clin; 2008 Oct 18; 4(4):425-38. PubMed ID: 18760754
    [Abstract] [Full Text] [Related]

  • 18. Renin angiotensin system blockade and nephropathy: why is it being called into question, and should it be?
    Hollenberg NK, Epstein M.
    Clin J Am Soc Nephrol; 2006 Sep 18; 1(5):1046-8. PubMed ID: 17699325
    [No Abstract] [Full Text] [Related]

  • 19. Inhibition of the renin-angiotensin system, with particular reference to dual blockade treatment.
    Andersen NH, Mogensen CE.
    J Renin Angiotensin Aldosterone Syst; 2001 Sep 18; 2(3):146-52. PubMed ID: 11881115
    [No Abstract] [Full Text] [Related]

  • 20. [Blocking the renin-angiotensin system in chronic kidney disease].
    Segura J.
    Nefrologia; 2004 Sep 18; 24 Suppl(6):101-12, 187-235. PubMed ID: 15696901
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 22.